Top Markets
Coin of the day
Kexing Biopharm Co., Ltd. Kexing Biopharm Co., Ltd.

Kexing Biopharm Co., Ltd.

688136
Rangering i aksjer #12095
Kexing Biopharm Co., Ltd. is a global pharmaceutical enterprise primarily... Kexing Biopharm Co., Ltd. is a global pharmaceutical enterprise primarily involved in the exploration, manufacturing, and commercialization of advanced recombinant protein-based drugs and microbial preparations, serving both the Chinese domestic market and international clientele. The company strategically directs its research and development endeavors towards crucial medical areas, specifically focusing on antiviral therapies, oncology, immunology, hematological conditions, digestive system health, and degenerative diseases. Its extensive product lineup features diverse pharmaceutical solutions. This includes innovative recombinant human proteins such as interferon a1b, erythropoietin, and granulocyte stimulating factor. Additionally, their offerings encompass microbial formulations like Clostridium butyricum combined live bacteria powder, traditional Chinese patent medicines (e.g., Kehuang Capsule), and chemical drugs like Entecavir. Kexing Biopharm also provides cutting-edge biologics, including liraglutide (a human glucagon-like peptide-1), along with other specialized therapeutics such as Albumin-Paclitaxel, Infliximab, Bevacizumab, adalimumab, trastuzumab, neratinib maleate tablets, and lenalidomide capsules. Established in 1989, the company's main operations are situated in Jinan, China.
Aksjekurs
$3.13
Sist synkronisert: 2026-08-28
Markedsverdi
$621.33M
Endring (1 dag)
-4.47%
Endring (1 år)
-49.66%
Land
CN
Handel Kexing Biopharm Co., Ltd. (688136)

Kategori

Aksjeprishistorikk for Kexing Biopharm Co., Ltd. (688136)
Høyeste sluttskurs: $3.08 den 2026-08-01

Laveste sluttskurs: $6.58 den 2020-12-01
Aksjeprishistorikk for Kexing Biopharm Co., Ltd. fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -7.82%
2025 76.11%
2024 -6.86%
2023 -20.39%
2022 -21.56%
2021 -31.83%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.20 -12.94%
AU
$138.18 473.58%
US
$759.27 7.20%
CH